Hypoxia-inducible factor 1 (HIF-1) 3 is a key regulator of hypoxic adaptation that functions by activating the transcription of several genes involved in angiogenesis, erythropoiesis, and glycolysis (1, 2). It consists of two subunits; HIF-1␣ is rapidly degraded under normoxic condition by the ubiquitin-proteasome system, whereas HIF-1 is stable. Under normoxic conditions the proline 564 and/or 402 residues of HIF-1␣ are hydroxylated by HIF-1␣-specific prolyl-4 hydroxylases (PHDs), which need O 2 , ␣-ketoglutarate, vitamin C, and Fe(II) (3-6). The hydroxylated prolines interact with von Hippel-Lindau (VHL) protein, a component of E3 ubiquitin ligase, and the HIF-1␣ is ubiquitinated by the VCB E3 ubiquitin-ligase complex, consisting of VHL protein, ElonginB, ElonginC, Cul2, and Rbx1 (7,8). In hypoxic conditions, proline hydroxylation decreases and HIF-1␣ accumulates. Oxygen molecules inhibit not only the stabilization of HIF-1␣ but also its transactivation activity, because the protein, factor-inhibiting HIF-1␣ (FIH-1), catalyzes hydroxylation of its asparagine residue using O 2 , ␣-ketoglutarate, vitamin C, and Fe(II). Hydroxylation of this asparagine residue in the transactivation domain of HIF-1␣ prevents it from recruiting its coactivator, cAMP-response element-binding protein (CBP) (3, 9).Thus, activation of HIF-1␣ is censored by two systems, proline hydroxylation and asparagine hydroxylation. HIF-1␣ and its targets, such as EPO and VEGF, are being evaluated as therapeutic agents for cerebral and myocardial infarctions, and a small lipophilic HIF-1␣-activating compound is being sought as a treatment for these diseases. However, to generate fully functional HIF-1␣, a putative HIF-1␣ activator should suppress both proline hydroxylation-dependent ubiquitination and asparagine hydroxylation.We showed previously that the zinc chelator N,N,NЈ,NЈ-tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) enhances the activity of PHD2 but that the level of HIF-1␣ protein does not fall because TPEN also inhibits its ubiquitination. Because TPEN does not prevent FIH-1 from hydroxylating the asparagine residue of HIF-1␣, it leads the accumulation of nonfunctional HIF-1␣ (10, 11). Here, we report that another zinc chelator, Clioquinol, which has relatively low affinity but high selectivity for Zn(II) and Cu(II), has a different effect on the activity of HIF-1␣. Both TPEN and Clioquinol inhibit ubiquitination of HIF-1␣ and cause its accumulation. However, in contrast to TPEN, Clioquinol prevents FIH-1 from hydroxylating HIF-1␣. It therefore stabilizes functional HIF-1␣, leading to expression of its target genes in normoxic cells.Clioquinol has been used in Alzheimer, Parkinson, and Huntington diseases as a Cu(II)-and Zn(II) chelator that reverses Zn(II)-or Cu(II)-induced metalloprotein precipitation (12). It
Hypoxia-induced gene expression is initiated when the hypoxia-inducible factor-1 (HIF-1) alpha subunit is stabilized in response to a lack of oxygen. An HIF-1alpha-specific prolyl-hydroxylase (PHD) catalyzes hydroxylation of the proline-564 and/or -402 residues of HIF-1alpha by an oxygen molecule. The hydroxyproline then interacts with the ubiquitin E3 ligase von Hippel Lindau protein and is degraded by an ubiquitin-dependent proteasome. PHD2 is the most active of three PHD isoforms in hydroxylating HIF-1alpha. Structural analysis showed that the N-terminal region of PHD2 contains a Myeloid translocation protein 8, Nervy, and DEAF1 (MYND)-type zinc finger domain, whereas the catalytic domain is located in its C-terminal region. We found that deletion of the MYND domain increased the activity of both recombinant PHD2 protein and in vitro-translated PHD2. The zinc chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine augmented the activity of wild-type PHD2-F but not that of PHD2 lacking the MYND domain, confirming that the zinc finger domain is inhibitory. Overexpression of PHD2 lacking the MYND domain caused a greater reduction in the stability and function of HIF-1alpha than did overexpression of wild-type PHD2, indicating that the MYND domain also inhibits the catalytic activity of PHD2 in vivo.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.